Speaker: Mark D. Okusa, MD

Topic:

"Kidney Injury: Immune responses and therapeutic intervention"

When:

Monday, November 13, 2006
12:00PM – 1:00PM
 

Location:

Baldwin Auditorium
Robert H. Lurie Medical Research Center
303 East Superior Street, 1st floor
  

Hosted by Yashpal Kanwar, MD

Li L, Okusa MD.  Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists.  Nat Clin Pract Nephrol. 2006 Aug;2(8):432-44.

Kalantarinia K, Okusa MD.  The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease.  Curr Diab Rep. 2006 Feb;6(1):8-16.

Day YJ, Huang L, Ye H, Li L, Linden J, Okusa MD.  Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma.  J Immunol. 2006 Mar 1;176(5):3108-14.

Hu DC, Burtner C, Hong A, Lobo PI, Okusa MD.  Correction of renal hypertension after kidney transplantation from a donor with Gitelman syndrome.  Am J Med Sci. 2006 Feb;331(2):105-9.

Portilla D, Okusa MD.  T cells and T-cell receptors in acute renal failure.  Kidney Int. 2006 Jan;69(2):208-10.

Awad AS, Ye H, Huang L, Li L, Foss FW Jr, Macdonald TL, Lynch KR, Okusa MD.  Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.  Am J Physiol Renal Physiol. 2006 Jun;290(6):F1516-24. Epub 2006 Jan 10.

Rosner MH, Gupta R, Ellison D, Okusa MD.  Management of cirrhotic ascites: physiological basis of diuretic action.  Eur J Intern Med. 2006 Jan;17(1):8-19.

Awad AS, Huang L, Ye H, Duong ET, Bolton WK, Linden J, Okusa MD.  Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.  Am J Physiol Renal Physiol. 2006 Apr;290(4):F828-37. Epub 2005 Dec 6.